Kiniksa is a publicly traded biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need.

Biotechnology

Kiniksa Pharmaceuticals

Sanj K. Patel

Paul Roussel

Jennifer Ring

Janice Stroughter

Kelsey Brown

Michael Megna

Bernie Kalmbach

Joseph J. Pirrello III

John McKenna

John F. Paolini M.D., Ph.D., Facc

Ross Moat

Chad Morin

Aaron Young

Chris Heberlig

Eben Tessari

Mike Megna

Rasmus Holm-Jorgensen

Mark Ragosa

Martina Struck

Melissa Manno

Dana Martin

John Paolini

Carsten Boess

Tom Beetham

Clinical Sales Specialists

Medical Affairs and Compliance

Leadership Team

Finance and Accounting

Marketing and Commercial Operations

Research and Development

Teams at Kiniksa Pharmaceuticals